Pralsetinib

Overview

Pralsetinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4582651).

API suppliers (2)

Suppliers of Pralsetinib backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• OLON SPAItaly1 active DMF
• VALARY LAB PRIVATE LIMITEDIndia1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Pralsetinib expires 7 Jul 2042 and exclusivity 1 Dec 2027. Generic API sourcing typically opens up once these lapse.